These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34092421)

  • 1. Independent and Interactive Effect of CYPs and GSTs Genetic Variants and Tobacco Smoking on the Risk of Non-Small Cell Lung Carcinoma.
    Pathak AK; Husain N; Kant S; Bala L
    Arch Med Res; 2021 Oct; 52(7):719-730. PubMed ID: 34092421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.
    El-Deek SEM; Abdel-Ghany SM; Hana RS; Mohamed AAR; El-Melegy NT; Sayed AA
    Mol Biol Rep; 2021 May; 48(5):4221-4232. PubMed ID: 34052967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.
    Butkiewicz D; Cole KJ; Phillips DH; Harris CC; Chorazy M
    Eur J Cancer Prev; 1999 Aug; 8(4):315-23. PubMed ID: 10493307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of lung cancer with polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 genotypes in the population of Inner Mongolia region.
    Jiang XY; Chang FH; Bai TY; Lv XL; Wang MJ
    Asian Pac J Cancer Prev; 2014; 15(13):5207-14. PubMed ID: 25040976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between cancer risk and drug-metabolizing enzyme gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1, and GSTT1) polymorphisms in cases of lung cancer in Japan.
    Tamaki Y; Arai T; Sugimura H; Sasaki T; Honda M; Muroi Y; Matsubara Y; Kanno S; Ishikawa M; Hirasawa N; Hiratsuka M
    Drug Metab Pharmacokinet; 2011; 26(5):516-22. PubMed ID: 21791872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility.
    Sunaga N; Kohno T; Yanagitani N; Sugimura H; Kunitoh H; Tamura T; Takei Y; Tsuchiya S; Saito R; Yokota J
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):730-8. PubMed ID: 12163326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
    Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
    Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
    Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis.
    Hung RJ; Boffetta P; Brockmöller J; Butkiewicz D; Cascorbi I; Clapper ML; Garte S; Haugen A; Hirvonen A; Anttila S; Kalina I; Le Marchand L; London SJ; Rannug A; Romkes M; Salagovic J; Schoket B; Gaspari L; Taioli E
    Carcinogenesis; 2003 May; 24(5):875-82. PubMed ID: 12771031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Polymorphisms of Xenobiotic Metabolizing Genes (GSTM1, GSTT1, GSTP1), Gene-Gene Interaction with Association to Lung Cancer Risk in North India; A Case Control Study.
    Ritambhara ; Tiwari S; Vijayaraghavalu S; Kumar M
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2707-2714. PubMed ID: 31554367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.
    Singh SA; Ghosh SK
    Pathol Oncol Res; 2019 Jan; 25(1):33-44. PubMed ID: 28952035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population.
    Rossini A; Rapozo DC; Soares Lima SC; Guimarães DP; Ferreira MA; Teixeira R; Kruel CD; Barros SG; Andreollo NA; Acatauassú R; Matos HJ; Albano RM; Pinto LF
    Carcinogenesis; 2007 Dec; 28(12):2537-42. PubMed ID: 17916905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTM1, GSTT1 and GSTP1 polymorphisms, environmental tobacco smoke exposure and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Schwartz AG
    Carcinogenesis; 2005 Feb; 26(2):395-401. PubMed ID: 15528218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Carcinogenesis; 2006 Mar; 27(3):525-32. PubMed ID: 16195240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
    Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
    Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
    Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.